ストックスクリーナーアプリを入手
45.13
0.29%
0.13
アフターアワーズ：
45.13
前日終値:
$45.00
開ける：
$45.2
24時間の取引高:
2.52M
Relative Volume:
1.88
時価総額：
$9.77B
収益：
$1.98B
当期純損益:
$83.59M
株価収益率:
120.67
EPS:
0.374
ネットキャッシュフロー:
$502.31M
1週間 パフォーマンス:
+7.32%
1か月 パフォーマンス:
+5.86%
6か月 パフォーマンス:
+1.03%
1年 パフォーマンス:
+2.90%
1日の値動き範囲:
$44.78
$45.41
1週間の範囲:
$43.54
$45.41
52週間の値動き範囲:
$37.74
$49.30
Qiagen Nv Stock (QGEN) Company Profile
QGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
45.13 | 9.11B | 1.98B | 83.59M | 502.31M | 0.374 |
|
TMO
Thermo Fisher Scientific Inc
|
402.82 | 148.60B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.90 | 132.07B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
513.36 | 40.34B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
111.92 | 30.82B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
140.33 | 23.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-04 | ダウングレード | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | アップグレード | Jefferies | Hold → Buy |
| 2024-10-17 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-06-27 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-12-07 | アップグレード | Goldman | Neutral → Buy |
| 2023-09-12 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-23 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-01-18 | アップグレード | DZ Bank | Hold → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-10-14 | 開始されました | Redburn | Buy |
| 2021-07-14 | ダウングレード | Kepler | Buy → Hold |
| 2021-06-03 | 開始されました | Goldman | Neutral |
| 2020-10-06 | 再開されました | BofA Securities | Buy |
| 2020-09-28 | アップグレード | Kepler | Hold → Buy |
| 2020-08-24 | アップグレード | Citigroup | Neutral → Buy |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-08-17 | アップグレード | Berenberg | Hold → Buy |
| 2020-08-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-08-14 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | ダウングレード | Berenberg | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-12-26 | 再開されました | BofA/Merrill | Underperform |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-11-14 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-11-14 | アップグレード | JP Morgan | Underweight → Overweight |
| 2019-11-14 | アップグレード | Kepler | Reduce → Hold |
| 2019-10-17 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | ダウングレード | Kepler | Hold → Reduce |
| 2019-10-08 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-10-08 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2019-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
すべてを表示
Qiagen Nv (QGEN) 最新ニュース
QIAGEN NV : Berenberg gives a Buy rating - marketscreener.com
Qiagen NV (QGEN) Trading 4% Higher on May 27 - GuruFocus
QIAGEN NV : Receives a Buy rating from DZ Bank - marketscreener.com
Cell-Free DNA Isolation and Extraction Market - GlobeNewswire Inc.
Europe Digital PCR Industry Research Report 2025: Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plans - GlobeNewswire Inc.
Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research - Insider Monkey
QIAGEN expands digital PCR oncology research portfolio through p - GuruFocus
QGEN Stock Might Gain Following New Partnership With ID Solutions - TradingView
Qiagen and ID Solutions collaborate on dPCR assays for oncology research - Medical Device Network
QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions - Silicon Canals
QIAGEN (QGEN) Expands dPCR Assay Availability Through New Partnership | QGEN Stock News - GuruFocus
QIAGEN (QGEN) Expands dPCR Assay Availability Through New Partne - GuruFocus
miRNA Sequencing and Assays Market Research Report 2025-2030 with Focus on 25+ Major Players Such as Abcam, HTG Molecular Diagnostics, Illumina, Lexogen, Meridian Bioscience - GlobeNewswire Inc.
QIAGEN acquires AI-powered software, Genoox - MSN
Here's Why Qiagen (QGEN) is a Strong Momentum Stock - Yahoo Finance
Qiagen Receives Notification of BlackRock’s Voting Rights - TipRanks
QIAGEN Stock Gains Following the Acquisition of Genoox - MSN
Here's Why Qiagen (QGEN) is a Strong Value Stock - Yahoo Finance
Qiagen Stock Beats Earnings, But Its Expensive Valuation Caps Upside Potential (NYSE:QGEN) - Seeking Alpha
Some Investors May Be Willing To Look Past Qiagen's (NYSE:QGEN) Soft Earnings - Yahoo Finance
BlackRock Increases Stake in Qiagen, Influencing Market Dynamics - TipRanks
Qiagen Receives Significant Voting Rights Notification from AFM - TipRanks
Qiagen’s Voting Rights Announcement Highlights BlackRock’s Influence - TipRanks
QIAGEN acquires Genoox to enhance genetic data analysis By Investing.com - Investing.com Nigeria
Qiagen Releases Q1 2025 Financial Report Highlighting Asset Decline - TipRanks
Transcript : Qiagen N.V. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 10 - marketscreener.com
Pluri (NASDAQ:PLUR) & Qiagen (NYSE:QGEN) Head to Head Contrast - Defense World
Qiagen (QGEN) Expands Genomic Capabilities with Genoox Acquisiti - GuruFocus
PTA-CMS: QIAGEN N.V.: Release of a capital market information - TradingView
Qiagen Acquires Genoox for $70 Million - marketscreener.com
QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software - 01net
QIAGEN acquires Genoox to enhance genetic data analysis - Investing.com Australia
Qiagen Acquires Genoox For $70 Million Plus $10 Million In Milestones - marketscreener.com
Qiagen (NYSE:QGEN) Shares Sold by First Trust Advisors LP - Defense World
Analysts Are Updating Their Qiagen N.V. (NYSE:QGEN) Estimates After Its First-Quarter Results - simplywall.st
Is Qiagen (NYSE:QGEN) A Risky Investment? - simplywall.st
The Qiagen N.V. (NYSE:QGEN) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance
Qiagen N.V. (NYSE:QGEN) Q1 2025 Earnings Call Transcript - Insider Monkey
QIAGEN Reports Strong Q1 2025 Results and Plans Dividend Initiation - TipRanks
QIAGEN NV : UBS sticks Neutral - marketscreener.com
Qiagen (NYSE:QGEN) Upgraded at StockNews.com - Defense World
QIAGEN Reports Strong Q1 2025 Earnings - TipRanks
Qiagen: Good start to 2025 - marketscreener.com
QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up - TradingView
QIAGEN NV : Gets a Buy rating from Deutsche Bank - marketscreener.com
Qiagen: Q1 Earnings Snapshot - Norwalk Hour
Qiagen N : QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase - marketscreener.com
QiagenH. Rusckowski To Succeed Lawrence A. Rosen As Chairman Of Supervisory Board Following AGM - marketscreener.com
QIAGEN announces plans for transition in leadership of Supervisory Board - BioSpace
Qiagen N : QIAGEN announces plans for transition in leadership of Supervisory Board - marketscreener.com
Qiagen Nv (QGEN) 財務データ
収益
当期純利益
現金流量
EPS
0.78%
1.71%
大文字化:
|
ボリューム (24 時間):